TerSera Therapeutics LLC
TerSera Therapeutics LLC, a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 2015, the company has rapidly established itself as a leader in developing innovative therapies for patients with unmet medical needs, particularly in the areas of oncology and rare diseases. With a focus on precision medicine, TerSera's core products include advanced therapeutics that leverage cutting-edge research and technology, setting them apart in a competitive market. The company has achieved significant milestones, including strategic partnerships and successful product launches, which have solidified its position as a trusted name in the healthcare sector. TerSera Therapeutics continues to drive advancements in treatment options, demonstrating a commitment to improving patient outcomes and enhancing the quality of life for those they serve.
DitchCarbon Score
How does TerSera Therapeutics LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
TerSera Therapeutics LLC's score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
TerSera Therapeutics LLC's reported carbon emissions
TerSera Therapeutics LLC, headquartered in the US, currently does not have available carbon emissions data for recent years, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions figures to analyse. In the absence of concrete emissions data, it is important to note that TerSera Therapeutics has not outlined any specific reduction targets or initiatives related to carbon emissions. Additionally, there are no commitments to the Science Based Targets initiative (SBTi) or other climate pledges mentioned. As the pharmaceutical industry increasingly focuses on sustainability and climate action, TerSera Therapeutics may need to establish clear climate commitments and reduction strategies to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
TerSera Therapeutics LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
